blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2324839

EP2324839 - GRANULOCYTE-COLONY-STIMULATING-FACTOR (G-CSF) FOR USE IN THE TREATMENT OF MYOCARDIAL INFARCT [Right-click to bookmark this link]
Former [2011/21]Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury
[2016/52]
StatusNo opposition filed within time limit
Status updated on  15.06.2018
Database last updated on 02.08.2024
FormerThe patent has been granted
Status updated on  07.07.2017
FormerGrant of patent is intended
Status updated on  18.01.2017
Most recent event   Tooltip26.06.2020Lapse of the patent in a contracting state
New state(s): CY		published on 29.07.2020  [2020/31]
Applicant(s)For all designated states
The Trustees of Columbia University in the City of New York
West 116th Street and Broadway New York
New York 10027 / US
[2011/21]
Inventor(s)01 / Itescu, Silviu
c/o Mesoblast Ltd.
Level 38, 55 Collins Street
Melbourne, VIC 3000 / AU
 [2017/32]
Former [2011/22]01 / Itescu, Silviu
Level 39 55 Collins Street
Melbourne, Victoria 3000 / AU
Former [2011/21]01 / Itescu, Silviu
Apartment 12E 279 East 44th Street
New York, NY 100017 / US
Representative(s)Steinecke, Peter, et al
Müller Fottner Steinecke
Rechtsanwalts- und Patentanwaltspartnerschaft mbB
Römerstrasse 16 b
52428 Jülich / DE
[2017/32]
Former [2011/21]Steinecke, Peter, et al
Müller Fottner Steinecke Rechtsanwälte - Patentanwälte Technologiezentrum Jülich Karl-Heinz-Beckurts-Strasse 13
52428 Jülich / DE
Application number, filing date10012752.105.06.2001
[2011/21]
Priority number, dateUS2000058744105.06.2000         Original published format: US 587441
[2011/21]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2324839
Date:25.05.2011
Language:EN
[2011/21]
Type: B1 Patent specification 
No.:EP2324839
Date:09.08.2017
Language:EN
[2017/32]
Search report(s)(Supplementary) European search report - dispatched on:EP26.04.2011
ClassificationIPC:A61K35/14, A61K35/28, A61K38/19, A61P9/10
[2016/52]
CPC:
A61K38/195 (EP,US); A61K35/44 (EP,US); A61K38/193 (EP,US);
A61P25/28 (EP); A61P3/10 (EP); A61P35/00 (EP);
A61P43/00 (EP); A61P7/02 (EP); A61P7/04 (EP);
A61P9/00 (EP); A61P9/04 (EP); A61P9/08 (EP);
A61P9/10 (EP); C07K16/24 (EP,US); C07K16/2866 (EP,US);
C12N5/0692 (EP,US); A61K2039/505 (EP,US); C07K14/52 (US);
C12N2501/21 (EP,US) (-)
Former IPC [2011/21]A61K35/14, A61K35/28, A61K38/19, A61K39/395, A61P35/00, A61P9/10
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2017/32]
Former [2011/21]AT,  BE,  CH,  CY,  DE,  DK,  ES,  FI,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE,  TR 
TitleGerman:GRANULOZYTEN-KOLONIE-STIMULIERENDER-FAKTOR (G-CSF) ZUR BEHANDLUNG VON HERZINFARKT[2016/52]
English:GRANULOCYTE-COLONY-STIMULATING-FACTOR (G-CSF) FOR USE IN THE TREATMENT OF MYOCARDIAL INFARCT[2016/52]
French:FILGRASTIM POUR USAGE DE TRAITEMENT DE L' INFARCTUS DU MYOCARD[2016/52]
Former [2011/21]Identifikation on Gebrauch von menschlichen Endothel Vorläuferzellen aus Knochenmark zur Verbesserung der Myokardfunktion nach ischämischem Insult
Former [2011/21]Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury
Former [2011/21]Identification et usage de cellules endothéliales humaines derivées de la moelle osseuse afin d'améliorer la fonction du myocarde aprés un insulte ischaemique
Examination procedure24.11.2011Amendment by applicant (claims and/or description)
24.11.2011Examination requested  [2012/01]
10.12.2014Despatch of a communication from the examining division (Time limit: M04)
16.04.2015Reply to a communication from the examining division
24.07.2015Despatch of a communication from the examining division (Time limit: M06)
27.01.2016Reply to a communication from the examining division
09.06.2016Despatch of a communication from the examining division (Time limit: M04)
17.10.2016Reply to a communication from the examining division
19.01.2017Communication of intention to grant the patent
19.05.2017Fee for grant paid
19.05.2017Fee for publishing/printing paid
19.05.2017Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP01942041.3  / EP1290033
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20010942041) is  20.03.2008
Opposition(s)11.05.2018No opposition filed within time limit [2018/29]
Fees paidRenewal fee
01.10.2010Renewal fee patent year 03
01.10.2010Renewal fee patent year 04
01.10.2010Renewal fee patent year 05
01.10.2010Renewal fee patent year 06
01.10.2010Renewal fee patent year 07
01.10.2010Renewal fee patent year 08
01.10.2010Renewal fee patent year 09
01.10.2010Renewal fee patent year 10
22.06.2011Renewal fee patent year 11
27.06.2012Renewal fee patent year 12
20.06.2013Renewal fee patent year 13
25.06.2014Renewal fee patent year 14
19.06.2015Renewal fee patent year 15
27.06.2016Renewal fee patent year 16
27.06.2017Renewal fee patent year 17
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT09.08.2017
CY09.08.2017
DK09.08.2017
ES09.08.2017
FI09.08.2017
IT09.08.2017
MC09.08.2017
NL09.08.2017
PT09.08.2017
SE09.08.2017
TR09.08.2017
GR10.11.2017
[2020/31]
Former [2020/27]AT09.08.2017
DK09.08.2017
ES09.08.2017
FI09.08.2017
IT09.08.2017
MC09.08.2017
NL09.08.2017
PT09.08.2017
SE09.08.2017
TR09.08.2017
GR10.11.2017
Former [2020/15]AT09.08.2017
DK09.08.2017
ES09.08.2017
FI09.08.2017
IT09.08.2017
MC09.08.2017
NL09.08.2017
SE09.08.2017
TR09.08.2017
GR10.11.2017
Former [2019/15]AT09.08.2017
DK09.08.2017
ES09.08.2017
FI09.08.2017
IT09.08.2017
MC09.08.2017
NL09.08.2017
SE09.08.2017
GR10.11.2017
Former [2018/28]AT09.08.2017
DK09.08.2017
ES09.08.2017
FI09.08.2017
IT09.08.2017
NL09.08.2017
SE09.08.2017
GR10.11.2017
Former [2018/21]AT09.08.2017
DK09.08.2017
ES09.08.2017
FI09.08.2017
NL09.08.2017
SE09.08.2017
GR10.11.2017
Former [2018/12]AT09.08.2017
ES09.08.2017
FI09.08.2017
NL09.08.2017
SE09.08.2017
GR10.11.2017
Former [2018/10]AT09.08.2017
FI09.08.2017
NL09.08.2017
SE09.08.2017
Former [2018/09]FI09.08.2017
NL09.08.2017
SE09.08.2017
Former [2018/08]FI09.08.2017
NL09.08.2017
Documents cited:Search[A]EP0897980  (SMITHKLINE BEECHAM CORP [US]) [A] 1,2 * paragraph 13 *
ExaminationWO9937751
 US5980887
    - TAKANO H ET AL, "PLEIOTROPIC EFFECTS OF CYTOKINES ON ACUTE MYOCARDIAL INFARCTION: G-CSF AS A NOVEL THERAPY FOR ACUTE MYOCARDIAL INFARCTION", CURRENT PHARMACEUTICAL DESIGN, BENTHAM SCIENCE PUBLISHERS, NL, (20030101), vol. 9, no. 14, doi:10.2174/1381612033455008, ISSN 1381-6128, pages 1121 - 1127, XP009042575

DOI:   http://dx.doi.org/10.2174/1381612033455008
by applicant   - MAHON NG ET AL., HEART, (1999), vol. 81, pages 478 - 82
    - PFEFFER JMPFEFFER MAFLETCHER PJBRAUNWALD E., AM J PHYSIOL, (1991), vol. 260, pages H1406 - 14
    - WHITE HD ET AL., CIRCULATION, (1987), vol. 76, pages 44 - 51
    - COLUCCI WS., AM J CARDIOL, (1997), vol. 80, no. 11A, pages 15L - 25L
    - RAVICHANDRAN LVPUVANAKRISHNAN R., BIOCHEM INTL, (1991), vol. 24, pages 405 - 414
    - AGOCHA ALEE H-WEGHALI-WEBB M., J MOL CELL CARDIOL, (1997), vol. 29, pages 2233 - 2244
    - HOCHMAN JSCHOO H., CIRCULATION, (1987), vol. 75, pages 299 - 306
    - WHITE HD ET AL., CIRCULATION, (1994), vol. 89, pages 61 - 67
    - NIDORF SMSIU SCGALAMBOS GWEYMAN AEPICARD MH., J AM COLL CARDIOL, (1992), vol. 20, pages 307 - 313
    - ASAHARA T ET AL., SCIENCE, (1997), vol. 275, pages 964 - 967
    - TAKAHASHI T ET AL., NAT MED, (1999), vol. 5, pages 434 - 438
    - ASAHARA T ET AL., CIRC RES, (1999), vol. 85, pages 221 - 228
    - KALKA C ET AL., PROC NATL ACAD SCI USA, (2000), vol. 97, pages 3422 - 3427
    - RAFII S ET AL., B, (1994), vol. 84, pages 10 - 19
    - SHI Q ET AL., BLOOD, (1998), vol. 92, pages 362 - 367
    - LIN YWEISDORF DJSOLOVEY AHEBBEL RP., J CLIN INVEST, (2000), vol. 105, pages 71 - 77
    - TAVIAN M ET AL., BLOOD, (1996), vol. 87, pages 67 - 72
    - JAFFREDO TGAUTIER REICHMANN ADIETERLEN-LIEVRE F, DEVELOPMENT, (1998), vol. 125, pages 4575 - 4583
    - KENNEDY M ET AL., NATURE, (1997), vol. 386, pages 488 - 493
    - CHOI KKENNEDY MKAZAROV APAPADIMITRIOUKELLER G., DEVELOPMENT, (1998), vol. 125, pages 725 - 732
    - ELEFANTY AGROBB LBIRNER RBEGLEY CG., BLOOD, (1997), vol. 90, pages 1435 - 1447
    - LABASTIE M-CCORTES FROMEO P-HDULAC CPEAULT B., BLOOD, (1998), vol. 92, pages 3624 - 3635
    - TSAI FY ET AL., NATURE, (1994), vol. 371, pages 221 - 225
    - OGAWA M ET AL., BLOOD, (1999), vol. 93, pages 1168 - 1177
    - PEICHEV M ET AL., BLOOD, (2000), vol. 95, pages 952 - 8
    - ASAHARA T ET AL., EMBO J, (1999), vol. 18, pages 3964 - 3972
    - KARAM RHEALY BPWICKER P., CIRCULATION, (1990), vol. 81, pages 238 - 246
    - OLIVETTI GCAPASSO JMMEGGS LGSONNENBLICK EHANVERSA P., CIRC RES, (1991), vol. 68, pages 856 - 869
    - BRAUNWALD EPFEFFER MA., AM J CARDIOL, (1991), vol. 68, no. D, pages 1 - 6D
    - NELISSEN-VRANCKEN HDEBETS JSNOECKX LDAEMEN MSMITS J., CIRCULATION, (1996), vol. 93, pages 349 - 355
    - HEYMANS S ET AL., NAT MED, (1999), vol. 5, pages 1135 - 1142
    - HART PH ET AL., BLOOD, (1991), vol. 77, pages 841 - 848
    - STACEY KJ ET AL., MOL CELL BIOL, (1995), vol. 15, pages 3430 - 3441
    - PEI X-H ET AL., CLIN EXP METASTASIS, (1998), vol. 16, pages 551 - 558
    - MCEWAN PEGRAY GASHERRY LWEBB DJKENYON CJ., CIRCULATION, (1998), vol. 98, pages 2765 - 2773
    - KAWANO H ET AL., CIRCULATION, (2000), vol. 101, pages 1130 - 1137
    - CHUA BHCHUA CCDIGLIO CASIU BB., BIOCHIM BIOPHYS ACTA, (1993), vol. 1178, pages 201 - 206
    - ITO H ET AL., J CLIN INVEST, (1993), vol. 92, pages 398 - 403
    - ROSSI APSACCHETTO ACESARI MPESSINA AC., CARDIOVASC RES, (1999), vol. 43, pages 300 - 307
    - DORFMAN DMWILSON DBBRUNS GAORKIN SH., J BIOL CHEM, (1992), vol. 267, pages 1279 - 85
    - TASAKA KKITAZUMI K., GEN PHARMACOL, (1994), vol. 25, pages 1059 - 69
    - KALKMAN EAJVAN HAREN PSAXENA PRSCHOEMAKER RG., J MOL CELL CARDIOL, (1997), vol. 29, pages 1487 - 1497
    - PFEFFER MA ET AL., N ENGL J MED, (1992), vol. 327, pages 669 - 677
    - "The SOLVD investigators", N ENGL J MED, (1991), vol. 325, pages 293 - 302
    - PITT B ET AL., LANCET, (1997), vol. 349, pages 747 - 752
    - STRIETER, RM. ET AL., "Interleukin-8: a corneal factor that induces neovascularization", AM. J. PATHOL., (1992), vol. 141, pages 1279 - 1284
    - KOCH, AE. ET AL., "Interleukin-8 (IL-8) as a macrophage-derived mediator of angiogenesis", SCIENCE, (1992), vol. 258, doi:doi:10.1126/science.1281554, pages 1798 - 1801, XP002063155

DOI:   http://dx.doi.org/10.1126/science.1281554
    - STRIETER, RM ET AL., "The functional role of the ELR motif in CXC chemokine-mediated angiogenesis", J. BIOL. CHEM., (1992), vol. 270, doi:doi:10.1074/jbc.270.45.27348, pages 27348 - 27357, XP002916076

DOI:   http://dx.doi.org/10.1074/jbc.270.45.27348
    - TACHIBANA, K. ET AL., "The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract", NATURE, (1998), vol. 393, doi:doi:10.1038/31261, pages 591 - 594, XP002922246

DOI:   http://dx.doi.org/10.1038/31261
    - RAFII S ET AL., "Isolation and characterization of human bone marrow microvascular endothelial cells: hematopoietic progenitor cell adhesion", BLOOD, (1994), vol. 84, pages 10 - 19, XP001179804
    - SHI, Q. ET AL., "Evidence for circulating bone marrow-derived endothelial cells", BLOOD, (1998), vol. 92, pages 362 - 367
    - LIN, Y.WEISDORF, D. J.SOLOVEY, A.HEBBEL, R. P., "Origins of circulating endothelial cells and endothelial outgrowth from blood", J. CLIN. INVEST., (2000), vol. 105, doi:doi:10.1172/JCI8071, pages 71 - 77, XP001180169

DOI:   http://dx.doi.org/10.1172/JCI8071
    - KENNEDY, M. ET AL., "A common precursor for primitive erythropoiesis and definitive haematopoiesis", NATURE, (1997), vol. 386, doi:doi:10.1038/386488a0, pages 488 - 493, XP009080456

DOI:   http://dx.doi.org/10.1038/386488a0
    - CHOI, K.KENNEDY, M.KAZAROV, A.PAPADIMITRIOUKELLER, G.A COMMON PRECURSOR FOR HEMATOPOIETIC AND ENDOTHELIAL CELLS, DEVELOPMENT, (1998), vol. 125, pages 725 - 732
    - ELEFANTY, A. G.ROBB, L.BIRNER, R.BEGLEY, C. G., "Hematopoietic-specific genes are not induced during in vitro differentiation of scl-null embryonic stem cells", BLOOD, (1997), vol. 90, pages 1435 - 1447, XP002125751
    - LABASTIE, M. C.CORTES, F.ROMEO, P. H.DULAC, C.PEAULT, B., "Molecular identity of hematopoietic precursor cells emerging in the human embryo", BLOOD, (1998), vol. 92, pages 3624 - 3635, XP002195470
    - FOLKMAN, J., "Therapeutic angiogenesis in ischemic limbs", CIRCULATION, (1998), vol. 97, pages 108 - 110
    - ASAHARA, T. ET AL., "Isolation of putative progenitor cells for endothelial angiogenesis", SCIENCE, (1997), vol. 275, doi:doi:10.1126/science.275.5302.964, pages 964 - 967, XP002460916

DOI:   http://dx.doi.org/10.1126/science.275.5302.964
    - TAKAHASHI, T. ET AL., "Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization", NAT. MED., (1999), vol. 5, doi:doi:10.1038/8462, pages 434 - 438, XP002918947

DOI:   http://dx.doi.org/10.1038/8462
    - KALKA, C. ET AL., "Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization", PROC. NATL. ACAD. SCI. USA, (2000), vol. 97, doi:doi:10.1073/pnas.070046397, pages 3422 - 3427, XP002204951

DOI:   http://dx.doi.org/10.1073/pnas.070046397
    - NELISSEN-VRANCKEN, H. J.DEBETS, J. J.SNOECKX L. H.DAEMEN, M. J.SMITS, J.F., "Time-related normalization of maximal coronary flow in isolated perfused hearts of rats with myocardial infarction", CIRCULATION, (1996), vol. 93, no. 2, pages 349 - 355
    - KALKMAN, E. A. ET AL., "Determinants of coronary reserve in rats subjected to coronary artery ligation or aortic banding", CARDIOVASC. RES., (1996), vol. 32, no. 6, pages 1088 - 1095
    - COLUCCI, W. S., "Molecular and cellular mechanisms of myocardial failure", AM. J. CARDIOL., (1997), vol. 80, no. 11A, pages 15L - 25L
    - RAVICHANDRAN, L. V.PUVANAKRISHNAN, R., "In vivo labeling studies on the biosynthesis and degradation of collagen in experimental myocardial myocardial infarction", BIOCHEM. INTL., (1991), vol. 24, pages 405 - 414, XP008061159
    - AGOCHA, A.LEE, H. W.EGHALI-WEBB, M., "Hypoxia regulates basal and induced DNA synthesis and collagen type I production in human cardiac fibroblasts: effects of TGF-beta, thyroid hormone, angiotensis II and basic fibroblast growth factor", J. MOL. CELL. CARDIOL., (1997), vol. 29, pages 2233 - 2244
    - MAHON, N. G. ET AL., "Hospital mortality of acute myocardial infarction in the thrombolytic era", HEART, (1999), vol. 81, pages 478 - 482
    - PFEFFER, J. M.PFEFFER, M. AFLETCHER, P. J.BRAUNWALD, E., "Progressive ventricular remodeling in rat with myocardial infarction", AM. J. PHYSIOL., (1991), vol. 260, pages H1406 - 414
    - WHITE, H. D. ET AL., "Left ventricular end systolic volume as the major determinant of survival after recovery from myocardial infa-rction", CIRCULATION, (1987), vol. 76, pages 44 - 51
    - FOLKMAN J., "Angiogenesis in cancer, vascular, rheumatoid and other disease", NAT. MED., (1995), vol. 1, doi:doi:10.1038/nm0195-27, page 27, XP000605147

DOI:   http://dx.doi.org/10.1038/nm0195-27
    - MURDOCH CMONK PNFINN A., "Cxc chemokine receptor expression on human endothelial cells", CYTOKINE, (1999), vol. 11, doi:doi:10.1006/cyto.1998.0465, pages 704 - 12, XP002326838

DOI:   http://dx.doi.org/10.1006/cyto.1998.0465
    - ANGIOLILLO, AL ET AL., "Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo", J EXP MED, (1995), vol. 182, doi:doi:10.1084/jem.182.1.155, pages 155 - 62, XP002916077

DOI:   http://dx.doi.org/10.1084/jem.182.1.155
    - FEIL CAUGUSTIN HG., "Endothelial cells differentially express functional CXC-chemokine receptor-4 (CXCR-4/fusin) under the control of autocrine activity and exogenous cytokines", BIOCHEM BIOPHYS RES COMMUN, (1998), vol. 247, doi:doi:10.1006/bbrc.1998.8499, pages 38 - 45, XP002922245

DOI:   http://dx.doi.org/10.1006/bbrc.1998.8499
    - TAVIAN, M. ET AL., "Aorta-associated CD34 hematopoietic cells in the early human embryo", BLOOD, (1996), vol. 87, pages 67 - 72, XP002911190
    - JAFFREDO, T.GAUTIER, R.EICHMANN, A.DIETERLEN-LIEVRE, F., "Intraaortic hemopoietic cells are derived from endothelial cells during ontogeny", DEVELOPMENT, (1998), vol. 125, pages 4575 - 4583
    - MOHLE RBAUTZ FRAFII SMOORE MABRUGGER WKANZ L., "The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1", BLOOD, (1998), vol. 91, pages 4523 - 30, XP002127667
    - IMAI, K. ET AL., "Selective secretion of chemoattractants for haemopoietic progenitor cells by bone marrow endothelial cells: a possible role in homing of haemopoietic progenior cells to bone marrow", BR J HAEMATOL, (1999), vol. 106, pages 905 - 11
    - PELED, A. ET AL., "Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4", SCIENCE, (1999), vol. 283, pages 845 - 88
    - PEICHEV M ET AL., "Expression of VEGFR-2 and AC133 by circulating human CD34 (+) cells identifies a population of functional endothelial precursors", BLOOD, (2000), vol. 95, pages 952 - 8
    - VOERMANS CGERRITSEN WRVON DEM BORNE AEVAN DER SCHOOT CE., "Increased migration of cord blood-derived CD34+ cells, as compared to bone marrow and mobilized peripheral blood CD34+ cells across uncoated or fibronectin-coated filters", EXP. HEMATOL., (2000), vol. 27, doi:doi:10.1016/S0301-472X(99)00113-7, pages 1806 - 14, XP003009556

DOI:   http://dx.doi.org/10.1016/S0301-472X(99)00113-7
    - JANOWSKA-WIECZOREK, A. ET AL., "Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34+ cells and their transmigration through reconstituted basement membrane", BLOOD, (1999), vol. 93, pages 3379 - 3390, XP002315163
    - MASURE, S.PROOST, P.VAN DAMME, J.OPDENAKKER, MD., "Purification and identification of 91-kDa neutrophil gelatinase. Release by the activating peptide interleukin-8", EUR. J. BIOCHEM., (1991), vol. 198, doi:doi:10.1111/j.1432-1033.1991.tb16027.x, pages 391 - 398, XP002006640

DOI:   http://dx.doi.org/10.1111/j.1432-1033.1991.tb16027.x
    - PUGIN, J. ET AL., "Human neutrophils secrete gelatinase B in vitro and in vivo in response to endotoxin and proinflammatory mediators", AM. J. RESPIR. CELL. MOL. BIOL., (1999), vol. 20, pages 458 - 464
    - PRUIJT JF ET AL., "Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the metalloproteinase gelatinase B (MMP-9)", PROC NATL ACAD SCI USA., (1999), vol. 96, no. 1, pages 0863 - 10868
    - HEYMANS, S. ET AL., "Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure", NAT. MED., (1999), vol. 5, doi:doi:10.1038/13459, pages 1135 - 1142, XP002215807

DOI:   http://dx.doi.org/10.1038/13459
    - HART, P. H. ET AL., "Activation of human monocytes by granulocyte-macrophage colony-stimulating factor: increased urokinase-type plasminogen activator activity", BLOOD, (1991), vol. 77, pages 841 - 848
    - STACEY, K. J.FOWLES, L. F.COLMAN, M. S.OSTROWSKI, M. C.HUME, D. A., "Regulation of urokinase-type plasminogen activator gene transcription by macrophage colony-stimulating factor", MOL. CELL. BID., (1995), vol. 15, pages 3430 - 3441
    - PEI, X. H. ET AL., "G-CSF increases secretion of urokinase-type plasminogen activator by human lung cancer cells", CLIN. EXP. METASTASIS, (1998), vol. 16, pages 551 - 558
    - SEMERAD, CL ET AL., "A role for G-CSF receptor signalling in the regulation of hematopoietic cell function but not lineage commitment or differentiation", IMMUNITY, (1999), vol. 11, pages 153 - 161
    - NAGASAWA, T ET AL., "Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1", NATURE, (1996), vol. 382, doi:doi:10.1038/382635a0, pages 635 - 638, XP002115695

DOI:   http://dx.doi.org/10.1038/382635a0
    - REMPEL SADUDAS SGE SGUTIERREZ JA., "Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma", CLINCANCERRES, (2000), vol. 6, pages 102 - 11, XP002326839
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.